Levetiracetam

From Wikipedia, the free encyclopedia

Levetiracetam
IUPAC name (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
Identifiers
CAS number [102767-28-2]
PubChem 441341
ATC code N03AX14
SMILES CC[C@@H](C(=O)N)N1CCCC1=O
Properties
Molecular formula C8H14N2O2
Molar mass 170.21 g mol-1
Appearance Fine white crystalline powder
Pharmacology
Bioavailability ~100%
Routes of
administration
Oral, Intravenous
Elimination
half-life
6 - 8 hr
Excretion Urinary
Legal status


?(US)

Pregnancy
category
C(US)
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox disclaimer and references

Levetiracetam (INN) (pronounced /lɛvɨtɪˈræsɨtæm/) is an anticonvulsant medication used to treat epilepsy. It is S- enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam. Along with other anticonvulsants like gabapentin, it is also sometimes used to treat neuropathic pain. Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc.

Levetiracetam has recently been approved in the United Kingdom as a monotherapy treatment for epilepsy. It is also used in veterinary medicine for similar purposes.

Contents

[edit] Side effects

Side effects include: hair loss; pins and needles sensation in the extremities; psychiatric symptoms ranging from irritability to depression; and other common side effects like headache and nausea. Recent literature[1] (and paper 2.163 in [2]) suggests that the addition of pyridoxine (vitamin B6) may curtail some of the psychiatric symptoms.

[edit] References

[edit] External links

[edit] See also